GILEAD SCIENCES, INC. — Director's Dealing 2017

Aug 23, 2017

SEC Form 4/A — Form 4/A

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2017-08-19

Reporting Person: Kramer Kelly A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-19	Common Stock	M	1339	—	Acquired	1339	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-19	Restricted Stock Unit	$	M	1339	Disposed		Common Stock (1339)	Direct

Footnotes

F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2: 100% of the restricted stock units vested on August 19, 2017.

F3: The original Form 4 filed on August 22, 2017 is amended by this Form 4/A to restate the number of derivative securities beneficially owned following the reported transaction(s). No other changes have been made to the original Form 4.